Difference between revisions of "DCE MRI Biomarker Ctte"
Jump to navigation
Jump to search
| (125 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{TOCright}} | {{TOCright}} | ||
| − | :Co-chairs: | + | :Co-chairs: Hendrik Laue, PhD; James O'Connor, MD, PhD |
| − | + | ||
| − | * [ | + | * [https://docs.google.com/spreadsheets/d/e/2PACX-1vRzQYPdYm51Ak3VYii84CtIDFiYRIylH2IkHQZxdAAjJTAVX4iRqlGl2tety1pnDFKN9kLxoKI-RcoM/pubhtml?gid=1048658726&single=true Roster] |
| Line 11: | Line 11: | ||
*[[Synthetic DCE-MRI Data]] | *[[Synthetic DCE-MRI Data]] | ||
| − | |||
| − | '''Approved | + | ==DCE MRI Meetings== |
| + | |||
| + | '''Recently Approved Call Summaries''' | ||
| − | *[[Media: | + | *[[Media:2023_12-11_QIBA-DCE-MRI_BC_Meeting_Summary-FINAL.pdf|December 11, 2023]] |
| − | *[[Media: | + | *[[Media:2023_11-13_QIBA-DCE-MRI_BC_Meeting_Summary-FINAL.pdf|November 13, 2023]] |
| − | *[[Media: | + | *[[Media:2023_10-23_QIBA-DCE-MRI_BC_Meeting_Summary-FINAL.pdf|October 23, 2023]] |
'''''[[DCE-MRI BC Call Summaries Archive]]''''' | '''''[[DCE-MRI BC Call Summaries Archive]]''''' | ||
| − | + | <br /> | |
| − | [[QIBA DCE-MRI Technical Committee Call Summaries]] | + | <br /> |
| + | * [[QIBA DCE-MRI Technical Committee Call Summaries|DCE-MRI TC Call Summaries Archive 2008-2012]] | ||
| + | * Earlier materials can be found on the [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]] page | ||
==Profile Development== | ==Profile Development== | ||
| − | + | *[[Media:QIBA DCE-Profile - v2.0 - Consensus Document.pdf|'''MR DCE-MRI Quantification (DCEMRI-Q) (V.2) - Stage 2: Consensus 2023-12-06''']] | |
| + | *[[Media: QIBA DCE v2.0-Stage1 Public Comment Profile.pdf| '''MR DCE-MRI Quantification (DCEMRI-Q) (V.2) - Stage 1: Public Comment 2020-12-09''']] | ||
*[[Media:Compliance v 1 7.doc|DCE-MRI Profile, Section IV Compliance-AG v1.7]] ''05-21-2014'' | *[[Media:Compliance v 1 7.doc|DCE-MRI Profile, Section IV Compliance-AG v1.7]] ''05-21-2014'' | ||
*[[Media:Compliance (2).doc|DCE-MRI Profile, Section IV Compliance-AG]] ''01-22-2014'' | *[[Media:Compliance (2).doc|DCE-MRI Profile, Section IV Compliance-AG]] ''01-22-2014'' | ||
| − | *[[Media:DCEMRIProfile v1 6-20111213.pdf|DCE-MRI Quantification Profile v1.6 2011-12-13 | + | *[[Media:DCEMRIProfile v1 6-20111213.pdf|'''DCE-MRI Quantification Profile v1.6 2011-12-13''']] |
*[[Media:Profile Literature Review 20110427 Rev1.xls|DCE-MRI Profile Supporting Literature Review]] ''Revised 05.02.2011'' | *[[Media:Profile Literature Review 20110427 Rev1.xls|DCE-MRI Profile Supporting Literature Review]] ''Revised 05.02.2011'' | ||
*[[Tools and recommendation for structured literature review]] | *[[Tools and recommendation for structured literature review]] | ||
*[[Archived DCE-MRI Profiles]] | *[[Archived DCE-MRI Profiles]] | ||
| − | |||
==Reference Materials== | ==Reference Materials== | ||
| Line 45: | Line 48: | ||
*[[Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson]] | *[[Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson]] | ||
| − | |||
| + | ==QIBA Funded Projects== | ||
| + | |||
| + | ====Round 1==== | ||
*[[VirtualScopics, Inc.]] | *[[VirtualScopics, Inc.]] | ||
**[[Media:DrJackson QIBA Phantom 09203 AMR3.pdf|Example RSNA DCE-MRI Phantom Data Analysis Report]] | **[[Media:DrJackson QIBA Phantom 09203 AMR3.pdf|Example RSNA DCE-MRI Phantom Data Analysis Report]] | ||
| Line 53: | Line 58: | ||
*[[The University of Texas M.D. Anderson Cancer Center]] | *[[The University of Texas M.D. Anderson Cancer Center]] | ||
| + | ====Round 2==== | ||
| + | |||
| + | *[[Media:4-UPenn-Test-Retest.-Yr2.pdf|Test-Retest Evaluation of Repeatability of DCE-MRI and DWI in Human Subjects]] | ||
| + | |||
| + | ====Round 3==== | ||
| + | |||
| + | *[[QIBA Artificial Data Evaluation Software]] | ||
| + | |||
| + | *[[Media:Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis.pdf|Project (J) Development of a Tool to Evaluate Software using Artificial DCE-MRI Data and Statistical Analysis (Fraunhofer MEVIS, Germany)]] | ||
| + | |||
| + | *[[Media:DCE-MRI Phantom Study to Evaluate the Impact of Parallel Imaging and B1 In-homogeneities at Different MR Field Strengths of 1.0T, 1.5T, and 3.0T.pdf | Project (H) DCE-MRI Phantom Study to Evaluate the Impact of Parallel Imaging and B1 In-homogeneities at Different MR Field Strengths of 1.0T, 1.5T, and 3.0T (University Hospital Cologne, Germany)]] | ||
| + | |||
| + | ====Round 4==== | ||
| − | + | *[[Media:Digital Reference Object for DCE-MRI Analysis Software Verification.pdf|Project (AA) Digital Reference Object for DCE-MRI Analysis Software Verification (Cleveland Clinic Foundation)]] | |
| − | *[[Media: | + | *[[Media:DRO for DCE-MRI Analysis Software Verification.pdf|Project (T) Digital Reference Object for DCE-MRI Analysis Software Verification 2 (Duke University)]] |
| + | *[[Media:RSNA DCE-MRI Phantom Automated Analysis Software Package Development.pdf|Project (U) RSNA DCE-MRI Phantom Automated Analysis Software Package Development (University of Wisconsin)]] | ||
| − | ==Round | + | ====Round 5==== |
| + | *[[Media:Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit.pdf | Project (K) Aggregated Measures of Agreement for QIB Validation-An Open Source Toolkit (Duke University)]] | ||
| − | *[[ | + | ====Round 6==== |
| + | *[[Media:Evaluation of RF Transmit Calibration Options for Quantitative DCE-MRI.pdf | Project (Z) Evaluation of RF Transmit Calibration Options for Quantitative DCE-MRI (University of Southern California)]] | ||
==Historical Background - Formation of the Group== | ==Historical Background - Formation of the Group== | ||
Latest revision as of 17:02, 17 January 2024
- Co-chairs: Hendrik Laue, PhD; James O'Connor, MD, PhD
Project Snapshot
Develop a quantitative imaging profile for Dynamic Contrast Enhanced MRI.
DCE MRI Meetings
Recently Approved Call Summaries
DCE-MRI BC Call Summaries Archive
- DCE-MRI TC Call Summaries Archive 2008-2012
- Earlier materials can be found on the PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee page
Profile Development
- MR DCE-MRI Quantification (DCEMRI-Q) (V.2) - Stage 2: Consensus 2023-12-06
- MR DCE-MRI Quantification (DCEMRI-Q) (V.2) - Stage 1: Public Comment 2020-12-09
- DCE-MRI Profile, Section IV Compliance-AG v1.7 05-21-2014
- DCE-MRI Profile, Section IV Compliance-AG 01-22-2014
- DCE-MRI Quantification Profile v1.6 2011-12-13
- DCE-MRI Profile Supporting Literature Review Revised 05.02.2011
Reference Materials
- T1 DRO Report -- 20130903 -- Dr Barboriak
- DWI Proposal for the DCE-MRI Tech Ctte 12.14.2011
- QIBA DCE-MRI Synthetic Data Presentation -- 20110929--Dr. Barboriak
- MR Phantom Development / Data Efforts - May 2010 QIBA Meeting Breakout Session
- Prototype Phantom - 20100203
- QIBA Quantitative MRI Poster for RSNA 2009 Annual Meeting
- DCE-MRI Phantom Study Protocol -- rev20091028
- Proposed Changes to Acquisition Protocol -- 20090315 - E Jackson